The Venture Codex Logo

The Venture Codex

Optum Ventures

75 State Street, 29th Floor, Boston, MA, 02109, United States

Overview

Optum Ventures provides capital and strategic guidance to startup companies solving health care's pressing challenges. It is the venture capital investment arm of Optum that invests in digital health companies that use data and insights to help improve consumers' access to health care services and how care is delivered and paid for, and that makes the health care system more reliable and easier to navigate.

Total investments
86
Lead investments
28
Investments · 12mo
11
Active investors
4

Sector focus

  • Finance
  • Financial Services
  • Health Care
  • Impact Investing
  • Venture Capital
Visit website

Investment portfolio

  • Bunkerhill Health

    Participated · Series B · Jul 2026

    Bunkerhill Health offers Carebricks, an agentic AI platform that lets hospitals and health systems turn internal ideas into production AI agents across clinical, operational, and administrative workflows. The platform is in use at major health systems including Cleveland Clinic, the University of Texas Medical Branch (UTMB), and Intermountain Health. At UTMB, Bunkerhill reports more than 20 AI agents live across clinical care, operations, and administration, with examples including a coronary calcium detection agent that flagged an imminent heart-attack risk, a nephrology triage agent that cut specialist wait times by more than 50 percent, and a lung nodule agent that addresses urgent cases 80 percent faster while doubling guideline-concordant follow-up. Financially, the company raised a $55 million Series B that brings total disclosed funding to $55 million. Bunkerhill plans to use the new capital to broaden the Carebricks platform and enhance governance, monitoring, and safeguards needed for deploying agentic AI at scale in health systems.

  • Adaptive Innovations

    Participated · Series A · Jun 2026

    Adaptive Innovations builds an AI-native operating system and clinical services platform for home healthcare that automates medical intake, scheduling, charting, compliance, and billing. The company reports it has delivered over 100,000 patient visits across Texas hospital networks and has reduced clinical rehospitalization rates to 4.9 percent. It also says practitioner documentation timelines have been reduced by roughly 80 percent. Leadership is led by Co-CEOs Alex Wendland and Logan Stinson, CTO Ryan Tolsma, and COO Hunter Stinson. Financially, the company has raised $60M to date, including the recent $50M Series A. Planned uses of the new capital include expanding engineering and operations headcount, accelerating software development, and entering new state markets.

  • Amigo AI

    Participated · Series A · Mar 2026

    Amigo AI is a New York-based platform that builds and rigorously trains autonomous clinical agents to interact directly with patients across workflows such as intake, triage, personalized care navigation, and continuous support. Each agent undergoes a “digital residency,” running millions of simulated scenarios—weighted toward edge cases—until it achieves a 100 % safety pass rate before touching real patients. In the past six months, Amigo agents have completed more than three million autonomous patient encounters worldwide without a single safety incident, and the system now serves organizations including Eucalyptus, Diverge Health, and The Care Clinic. The architecture mirrors clinicians’ cognitive processes, shares real-time context across multiple agents, and integrates natively with major EHRs like Epic, Oracle Health, and Athenahealth while maintaining HIPAA, SOC 2 Type II, and GDPR compliance. Amigo’s multilingual capability (100+ languages) and ability to extend existing care teams position it to help address the projected 11 million-provider shortfall by 2030. Strategic hires such as Dr. Jay Shah, Chief of the Medical Staff at Stanford Health Care, reinforce its clinical credibility. Financially, the company has raised $17 million to date, including a recently closed $11 million Series A round.

  • Greater Good Health

    Participated · Series B · Mar 2026

    Greater Good Health partners with health plans, hospital systems, and provider groups to offer nurse practitioner–led primary care clinics and embedded clinical programs that lower total cost of care while improving quality and access. The company currently serves more than 200,000 patients through its clinics and integrated services platform, achieving 4-plus STAR quality scores, over 200 % growth in preventive-care engagement, reduced unnecessary acute admissions, and a Net Promoter Score above 90. Its first three clinics launched in Montana with Humana, and a fourth clinic opened in Idaho with Blue Cross of Idaho, highlighting the model’s scalability in underserved, aging markets. Based in El Segundo, California, Greater Good Health focuses on Medicare adults and addresses the national shortage of primary care physicians by elevating nurse practitioners to lead care teams. The organization functions as an extension of risk-bearing entities, supplying the infrastructure and staffing needed for longitudinal, value-based care management. With fresh capital, the company plans to deepen payer partnerships, strengthen its technology-enabled care platform, and expand into additional geographies.

  • Chamber Cardio

    Participated · Series A · Feb 2026

    Chamber Cardio is building the infrastructure needed for cardiologists to thrive under value-based care contracts. Its workflow-native platform ingests cardiology data and uses artificial intelligence to flag high-risk patients, identify gaps in guideline-directed therapy, and cut down on manual chart review. These insights are paired with operational support aimed at reducing preventable complications and hospital utilization while improving patient experience and giving payers clearer visibility into total cost of care. The company already partners with multiple health plans and works with more than 500 cardiologists across seven states. Fresh capital will be deployed to deepen health-plan and practice partnerships, enter additional markets, and grow Chamber’s clinical, operational, and technology teams. Following its $60 million Series A, backed by leading health-tech investors, Chamber is positioned to accelerate national expansion in a market where cardiovascular disease remains one of the largest drivers of U.S. healthcare spending.

Team